Search for a security

Equities results (51)

Fervi SpAFVI:MILBorsa Italia MTA (Equities)Italy
Finlogic SpAFNL:MILBorsa Italia MTA (Equities)Italy
Farmae SpAFAR:MILBorsa Italia MTA (Equities)Italy
Friulchem SpAFCM:MILBorsa Italia MTA (Equities)Italy
Fope SpAFPE:MILBorsa Italia MTA (Equities)Italy
Giorgio Fedon & Figli SpAFED:MILBorsa Italia MTA (Equities)Italy
Fincantieri SpAFCT:MILBorsa Italia MTA (Equities)Italy
Fine Foods & Pharmaceuticals NTM SpAFF:MILBorsa Italia MTA (Equities)Italy
H-Farm SpAFARM:MILBorsa Italia MTA (Equities)Italy
Italian Food & Beverage CorpIFBC:PKLOTC Markets Group Inc - Limited InformationUnited States
Birla Sun Life Fxd Trm Pl-ID(1094 days)-GrowthLP68079580:LIPLipper
Birla Sun Life Fxd Trm Pl-ID(1094 days)-GrowthLP68079572:LIPLipper
Birla Sun Life Fxd Trm Pl-ID(1094 days)-GrowthLP68169576:LIPLipper
Birla Sun Life Fxd Trm Pl-ID(1094 days)-GrowthLP68079786:LIPLipper
Birla Sun Life Fxd Trm Pl-ID(1094 days)-GrowthLP68089156:LIPLipper
Opportunita Italia Fondo Comune di Investimento Immobiliare di tipo chiusoQFOPI:MILBorsa Italia MTA (Equities)Italy
Idaho First BankIDFB:PKCOTC Markets Group Inc - Current InformationUnited States
Kisses From Italy IncKITL:QBBOTC Markets Group Inc - OTCQBUnited States
Gabelli Value for Italy SPAVALU:MILBorsa Italia MTA (Equities)Italy
StrateVic Finance Group ABSVAB:DEUGerman CompositeGermany
UTI Dual Advantage Fixed Term-II-II(1997D)-GthLP68336047:LIPLipper
UTI Dual Advantage Fixed Term-II-II(1997D)-GthLP68336048:LIPLipper
UTI Dual Advantage Fixed Term-II-II(1997D)-GthLP68336049:LIPLipper
UTI Dual Advantage Fixed Term-II-II(1997D)-GthLP68336050:LIPLipper
Freni Brembo SpABRBOY:PNKGrey MarketUnited States
First Idaho Resources IncFI.H:NEXTSX Venture Exchange NEXCanada
First Idaho Resources IncFRIRF:PNKGrey MarketUnited States
UTI Dual Advantage Fixed Term-II-I(1998D)-GthLP68336270:LIPLipper
UTI Dual Advantage Fixed Term-II-I(1998D)-GthLP68336272:LIPLipper
UTI Dual Advantage Fixed Term-II-I(1998D)-GthLP68336271:LIPLipper
UTI Dual Advantage Fixed Term-II-I(1998D)-GthLP68336273:LIPLipper
Fresenius Medical Care AG & Co KGaAFME:MILBorsa Italia MTA (Equities)Italy
Fresenius SE & Co KGaAFRE:MILBorsa Italia MTA (Equities)Italy
FILA Fabbrica Italiana Lapis ed Affini SpAFILA:MILBorsa Italia MTA (Equities)Italy
FILA Fabbrica Italiana Lapis ed Affini SpA0QIQ:LSELondon Stock ExchangeUnited Kingdom
FILA Fabbrica Italiana Lapis ed Affini SpA3S0:BERBerlin Stock ExchangeGermany
FILA Fabbrica Italiana Lapis ed Affini SpA3S0:DEUGerman CompositeGermany
FILA Fabbrica Italiana Lapis ed Affini SpA3S0:FRAGerman Stock ExchangeGermany
FILA Fabbrica Italiana Lapis ed Affini SpA3S0:STUStuttgart Stock ExchangeGermany
FILA Fabbrica Italiana Lapis ed Affini SpAFILAm:EBTEuronext Block
Facebook IncFB:MILBorsa Italia MTA (Equities)Italy
Falck Renewables SpAFKR:MILBorsa Italia MTA (Equities)Italy
First Capital SpAFIC:MILBorsa Italia MTA (Equities)Italy
Fintel Energia Group SpAFTL:MILBorsa Italia MTA (Equities)Italy
FinecoBank Banca Fineco SpAFBK:MILBorsa Italia MTA (Equities)Italy
Frendy Energy SpAFDE:MILBorsa Italia MTA (Equities)Italy
Fullsix SpAFUL:MILBorsa Italia MTA (Equities)Italy
Fiat Chrysler Automobiles NVFCA:MILBorsa Italia MTA (Equities)Italy
Fidia SpAFDA:MILBorsa Italia MTA (Equities)Italy
FNM SpAFNM:MILBorsa Italia MTA (Equities)Italy
Fiera Milano SpAFM:MILBorsa Italia MTA (Equities)Italy
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on is subject to the FT Terms & Conditions
All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.